Chaubal M - Search Results

1

Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages.

Dou H, Morehead J, Destache CJ, Kingsley JD, Shlyakhtenko L, Zhou Y, Chaubal M, Werling J, Kipp J, Rabinow BE, Gendelman HE. Dou H, et al. Among authors: chaubal m. Virology. 2007 Feb 5;358(1):148-58. doi: 10.1016/j.virol.2006.08.012. Epub 2006 Sep 25. Virology. 2007. PMID: 16997345 Free article.

2

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.

Dou H, Destache CJ, Morehead JR, Mosley RL, Boska MD, Kingsley J, Gorantla S, Poluektova L, Nelson JA, Chaubal M, Werling J, Kipp J, Rabinow BE, Gendelman HE. Dou H, et al. Among authors: chaubal m. Blood. 2006 Oct 15;108(8):2827-35. doi: 10.1182/blood-2006-03-012534. Epub 2006 Jun 29. Blood. 2006. PMID: 16809617 Free PMC article.

3

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

Dou H, Grotepas CB, McMillan JM, Destache CJ, Chaubal M, Werling J, Kipp J, Rabinow B, Gendelman HE. Dou H, et al. Among authors: chaubal m. J Immunol. 2009 Jul 1;183(1):661-9. doi: 10.4049/jimmunol.0900274. Epub 2009 Jun 17. J Immunol. 2009. PMID: 19535632 Free PMC article.

4

NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

Nowacek AS, Miller RL, McMillan J, Kanmogne G, Kanmogne M, Mosley RL, Ma Z, Graham S, Chaubal M, Werling J, Rabinow B, Dou H, Gendelman HE. Nowacek AS, et al. Among authors: chaubal m. Nanomedicine (Lond). 2009 Dec;4(8):903-17. doi: 10.2217/nnm.09.71. Nanomedicine (Lond). 2009. PMID: 19958227 Free PMC article.

5

Paclitaxel nanosuspensions for targeted chemotherapy - nanosuspension preparation, characterization, and use.

Lee SE, Bairstow SF, Werling JO, Chaubal MV, Lin L, Murphy MA, DiOrio JP, Gass J, Rabinow B, Wang X, Zhang Y, Yang Z, Hoffman RM. Lee SE, et al. Among authors: chaubal mv. Pharm Dev Technol. 2014 Jun;19(4):438-53. doi: 10.3109/10837450.2013.789911. Epub 2013 Apr 25. Pharm Dev Technol. 2014. PMID: 23617261

6

Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects.

Wong J, Brugger A, Khare A, Chaubal M, Papadopoulos P, Rabinow B, Kipp J, Ning J. Wong J, et al. Among authors: chaubal m. Adv Drug Deliv Rev. 2008 May 22;60(8):939-54. doi: 10.1016/j.addr.2007.11.008. Epub 2008 Feb 7. Adv Drug Deliv Rev. 2008. PMID: 18343527 Review.

7

Advances in lipid nanodispersions for parenteral drug delivery and targeting.

Constantinides PP, Chaubal MV, Shorr R. Constantinides PP, et al. Among authors: chaubal mv. Adv Drug Deliv Rev. 2008 Mar 17;60(6):757-67. doi: 10.1016/j.addr.2007.10.013. Epub 2007 Nov 6. Adv Drug Deliv Rev. 2008. PMID: 18096269 Review.

8

Conversion of nanosuspensions into dry powders by spray drying: a case study.

Chaubal MV, Popescu C. Chaubal MV, et al. Pharm Res. 2008 Oct;25(10):2302-8. doi: 10.1007/s11095-008-9625-0. Epub 2008 May 29. Pharm Res. 2008. PMID: 18509597

9

Application of drug delivery technologies in lead candidate selection and optimization.

Chaubal MV. Chaubal MV. Drug Discov Today. 2004 Jul 15;9(14):603-9. doi: 10.1016/S1359-6446(04)03171-X. Drug Discov Today. 2004. PMID: 15239979 Review.

10

Polyphosphates and other phosphorus-containing polymers for drug delivery applications.

Chaubal MV, Gupta AS, Lopina ST, Bruley DF. Chaubal MV, et al. Crit Rev Ther Drug Carrier Syst. 2003;20(4):295-315. doi: 10.1615/critrevtherdrugcarriersyst.v20.i4.20. Crit Rev Ther Drug Carrier Syst. 2003. PMID: 14635982 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters